VERAX Trademark
Trademark Overview
On Thursday, December 19, 2002, a trademark application was filed for VERAX with the United States Patent and Trademark Office. The USPTO has given the VERAX trademark a serial number of 78196256. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, December 1, 2003. This trademark is owned by Ribozyme Pharmaceuticals Incorporated. The VERAX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
medicinal and biological preparations for research and laboratory use, namely, preparations for the modulation of gene expression working at DNA, transcription, RNA or translation processes.
medicinal and biological preparations for pharmaceutial, clinical or medical laboratory use, namely, preparations for the modulation of gene expression working at DNA, transcription, RNA or translation processes.
medicinal and biological product research, development and testing.
General Information
| Serial Number | 78196256 |
| Word Mark | VERAX |
| Filing Date | Thursday, December 19, 2002 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, December 1, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | medicinal and biological preparations for research and laboratory use, namely, preparations for the modulation of gene expression working at DNA, transcription, RNA or translation processes. |
| Goods and Services | medicinal and biological preparations for pharmaceutial, clinical or medical laboratory use, namely, preparations for the modulation of gene expression working at DNA, transcription, RNA or translation processes. |
| Goods and Services | medicinal and biological product research, development and testing. |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 8, 2003 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 8, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 8, 2003 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ribozyme Pharmaceuticals Incorporated |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
Trademark Events
| Event Date | Event Description |
| Monday, December 1, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, April 23, 2003 | NON-FINAL ACTION E-MAILED |
| Thursday, April 17, 2003 | ASSIGNED TO EXAMINER |
